Advanced cervical cancer in young women: imaging study of late and very late radiation-related side effects after successful treatment by combined radiotherapy
Status PubMed-not-MEDLINE Jazyk angličtina Země Čína Médium print
Typ dokumentu časopisecké články
PubMed
33392008
PubMed Central
PMC7719935
DOI
10.21037/qims-20-553
PII: qims-11-01-21
Knihovny.cz E-zdroje
- Klíčová slova
- Radiation-induced tumor, arterio-ureteral fistula, bone, complication, toxicity,
- Publikační typ
- časopisecké články MeSH
BACKGROUND: Radical combined radiotherapy (RT) is a standard treatment for advanced cervical cancer. The aim of our study was to identify morphological late (≥6 months) and very late (≥5 years) radiation-related comorbidities on computed tomography (CT), positron emission tomography/computerized tomography (PET/CT) or magnetic resonance imaging (MRI) scans in young females who survived ≥5 years since RT and were considered as successfully treated. Secondly, we studied a rate of clinically silent radiation-related toxicities apparent on imaging scans that might influenced on future well-being of survived females. Thirdly, we analyzed reasons why patients underwent imaging scans. METHODS: We included 41 subjects aged under 50 years (mean 41.8±7.2 years, median 41 years), who survived ≥5 years since RT, with at least one available imaging scan ≥3 years since RT. The mean time between RT and the last available scan was 12.3±7.9 years (median 9 years); the mean time of clinical follow-up was 15.4±7.1 years (median 14 years). RESULTS: Fourteen (34.1%) females underwent the first imaging scan in emergency situation and 27 (65.9%) patients due to variable chronic complaints. Grade III-V radiation-related comorbidities occurred in 19 (46.3%) females including one case of death due to radiation-induced osteosarcoma. In 14 of 19 patients, comorbidities were multiple. Four (9.8%) females suffered from life-threatening complications (grade IV): one from an uretero-arterial fistula with massive hematuria and 3 from bowel perforations. Eleven (26.8%) subjects suffered from bowel strictures with ileus development, they underwent mean 1.7±0.8 surgery (median 1.5). The mean time since RT to the first surgery for intestinal complications was 5.4±6.0 years (median 3 years), to the second 12.0±9.6 years (median 11.5 years) and to the third surgery 9.0±4.2 years (median 9 years). Late fistulas formations (vesico-recto-vaginal) were seen in 6 (14.6%) patients. Bone complications were diagnosed in 9 (22.0%) of treated females, one case of osteosarcoma included, 4 of 9 bone complications were clinically silent. In 5 (12.2%) subjects, toxicities grade III-IV first time manifested >5 years since RT, majority of them were multiple. The bowel perforation and fistulas formations were the earliest manifested grade III-IV toxicities, with median time 3 years since RT, the bone complications were the latest manifested with median time 16 years since RT. CONCLUSIONS: Our study is not able to bring information about the incidence of late and very late radiation related comorbidities, according to International Federation of Gynecology and Obstetrics (FIGO) recommendations patients are clinically followed only for 5 years and imaging cross-sectional scans are not recommended. However, our study shows that if females successfully treated for advanced cervical cancer report abdominal/pelvic clinical problems, it is highly probable their imaging scans will reveal late radiation related side-effects that may affect the rest of their life. It puts forward question whether females after radical RT should been regularly followed by cross-sectional imaging methods.
Zobrazit více v PubMed
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136:E359-86. 10.1002/ijc.29210 PubMed DOI
Bhatla N, Aoki D, Sharma DN, Sankaranarayanan R. Cancer of the cervix uteri. Int J Gynaecol Obstet 2018;143 Suppl 2:22-36. 10.1002/ijgo.12611 PubMed DOI
Viswanathan AN, Lee LJ, Eswara JR, Horowitz NS, Konstantinopoulos PA, Mirabeau-Beale KL, Rose BS, von Keudell AG, Wo JY. Complications of pelvic radiation in patients treated for gynecologic malignancies. Cancer 2014;120:3870-83. 10.1002/cncr.28849 PubMed DOI
Singh GK, Yadav V, Singh P, Bhowmik KT. Radiation-Induced Malignancies Making Radiotherapy a "Two-Edged Sword": A Review of Literature. World J Oncol 2017;8:1-6. 10.14740/wjon996w PubMed DOI PMC
Common terminology criteria for adverse events v5.0. Available online: https://www.meddra.org/
Castelnau-Marchand P, Chargari C, Maroun P, Dumas I, Del Campo ER, Cao K, Petit C, Martinetti F, Tafo-Guemnie A, Lefkopoulos D, Morice P, Haie-Meder C, Mazeron R. Clinical outcomes of definitive chemoradiation followed by intracavitary pulsed-dose rate image-guided adaptive brachytherapy in locally advanced cervical cancer. Gynecol Oncol 2015;139:288-94. 10.1016/j.ygyno.2015.09.008 PubMed DOI
Ribeiro I, Janssen H, De Brabandere M, Nulens A, De Bal D, Vergote I, Van Limbergen E. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients. Radiother Oncol 2016;120:447-54. 10.1016/j.radonc.2016.04.016 PubMed DOI
Misra S, Lal P, Kumar Ep S, Rastogi N, Tiwari A, Singh S, Das KJM, Kumar S. Comparative assessment of late toxicity in patients of carcinoma cervix treated by radiotherapy versus chemo-radiotherapy - Minimum 5 years follow up. Cancer Treat Res Commun 2018;14:30-6. 10.1016/j.ctarc.2017.11.007 PubMed DOI
Pillai AK, Anderson ME, Reddick MA, Sutphin PD, Kalva SP. Ureteroarterial fistula: diagnosis and management. AJR Am J Roentgenol 2015;204:W592-8. 10.2214/AJR.14.13405 PubMed DOI
Braunstein S, Nakamura JL. Radiotherapy-induced malignancies: review of clinical features, pathobiology, and evolving approaches for mitigating risk. Front Oncol 2013;3:73. 10.3389/fonc.2013.00073 PubMed DOI PMC
Cahan WG, Woodard HQ, Higinbotham NL, Stewart FW, Coley BL. Sarcoma arising in irradiated bone: report of eleven cases. Cancer 1998;82:8-34. 10.1002/(SICI)1097-0142(19980101)82:1<8::AID-CNCR3>3.0.CO;2-W PubMed DOI
Hall EJ, Wuu CS. Radiation-induced second cancers: the impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys 2003;56:83-8. 10.1016/S0360-3016(03)00073-7 PubMed DOI
Kwon JW, Huh SJ, Yoon YC, Choi SH, Jung JY, Oh D, Choe BK. Pelvic bone complications after radiation therapy of uterine cervical cancer: evaluation with MRI. AJR Am J Roentgenol 2008;191:987-94. 10.2214/AJR.07.3634 PubMed DOI
Papadopoulou I, Stewart V, Barwick TD, Park WH, Soneji N, Rockall AG, Bharwani N. Post-Radiation Therapy Imaging Appearances in Cervical Carcinoma. Radiographics 2016;36:538-53. 10.1148/rg.2016150117 PubMed DOI
Lundin B, Björkholm E, Lundell M, Jacobsson H. Insufficiency fractures of the sacrum after radiotherapy for gynaecological malignancy. Acta Oncol 1990;29:211-5. 10.3109/02841869009126547 PubMed DOI
Schmeler KM, Jhingran A, Iyer RB, Sun CC, Eifel PJ, Soliman PT, Ramirez PT, Frumovitz M, Bodurka DC, Sood AK. Pelvic fractures after radiotherapy for cervical cancer: implications for survivors. Cancer 2010;116:625-30. 10.1002/cncr.24811 PubMed DOI PMC